Angiotensin inhibition and malignancies: a review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.nature.com/articles/jhh200921.pdf
Reference81 articles.
1. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998; 352: 179–184.
2. Deshayes F, Nahmias C . Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005; 16: 293–299.
3. Folkman J, Watson K, Ingber D, Hanahan D . Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58–61.
4. Escobar E, Rodriguez-Reyna TS, Arrieta O, Sotelo J . Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2004; 2: 385–399.
5. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A . Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006; 15: 1929–1934.
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Causal linkage between angiotensin-converting enzyme 2 and risk of lung cancer: a bidirectional two-sample Mendelian randomization study;Frontiers in Medicine;2024-07-08
2. Genetic variants in the renin-angiotensin-aldosterone system: Impact on cancer risk, prognosis, and therapeutic directions;Vitamins and Hormones;2024
3. Diverse biological functions of the renin‐angiotensin system;Medicinal Research Reviews;2023-11-10
4. Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma;Cancer Cell International;2023-09-24
5. Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension;Journal of the Renin-Angiotensin-Aldosterone System;2023-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3